ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Cambrex rides a wave to further expansion

by Rick Mullin
August 8, 2016 | APPEARED IN VOLUME 94, ISSUE 32

Following a $50 million expansion of its active pharmaceutical ingredients facility in Charles City, Iowa, earlier this year, fine chemicals maker Cambrex is already considering its next expansion at the site as well as improvements at plants in Sweden and Italy. The firm said on an earnings conference call that it expects to announce the projects, likely to cost about $20 million, by the end of the year. CEO Steven Klosk noted that the new capacity in Charles City is filling up quickly.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment